Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-22

Clinical Trial Update: Dose Response Study of Dexmedetomidine in Orthopaedic Spine Surgery Patients [Phase 4]

View source ↗

Summary

A Phase 4 dose-response study evaluating dexmedetomidine in postoperative orthopedic spine surgery patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Pain, Postoperative | Phase 4 | Status: COMPLETED